Leflunomide has incremental cost advantage in RA

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 318, 2001 , pp. 7-7(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Cost-minimisation; Infliximab, therapeutic use; Leflunomide, therapeutic use; Methotrexate, therapeutic use; Rheumatoid-arthritis, treatment

Language: English

Document Type: Research article

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$27.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A